Literature DB >> 31504819

Comment on "Hypometabolic gliomas on FET-PET-is there an inverted U-curve for survival?"

Norbert Galldiks1,2,3, Antoine Verger4, Timothée Zaragori4, Marcus Unterrainer5, Bogdana Suchorska6, Philipp Lohmann2, Jörg C Tonn6, Karl-Josef Langen2,3,7, Nathalie L Albert5.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31504819      PMCID： PMC6917398          DOI： 10.1093/neuonc/noz173

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  6 in total

Review 1.  Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.

Authors:  Nathalie L Albert; Michael Weller; Bogdana Suchorska; Norbert Galldiks; Riccardo Soffietti; Michelle M Kim; Christian la Fougère; Whitney Pope; Ian Law; Javier Arbizu; Marc C Chamberlain; Michael Vogelbaum; Ben M Ellingson; Joerg C Tonn
Journal:  Neuro Oncol       Date:  2016-04-21       Impact factor: 12.300

2.  Hypometabolic gliomas on FET-PET-is there an inverted U-curve for survival?

Authors:  David Olayinka Kamson
Journal:  Neuro Oncol       Date:  2019-10-09       Impact factor: 12.300

3.  Photopenic defects on O-(2-[18F]-fluoroethyl)-L-tyrosine PET: clinical relevance in glioma patients.

Authors:  Norbert Galldiks; Marcus Unterrainer; Natalie Judov; Gabriele Stoffels; Marion Rapp; Philipp Lohmann; Franziska Vettermann; Veronika Dunkl; Bogdana Suchorska; Jörg C Tonn; Friedrich-Wilhem Kreth; Gereon R Fink; Peter Bartenstein; Karl-Josef Langen; Nathalie L Albert
Journal:  Neuro Oncol       Date:  2019-10-09       Impact factor: 12.300

Review 4.  Advances in neuro-oncology imaging.

Authors:  Karl-Josef Langen; Norbert Galldiks; Elke Hattingen; Nadim Jon Shah
Journal:  Nat Rev Neurol       Date:  2017-04-07       Impact factor: 42.937

5.  Non-invasive grading of brain tumours using dynamic amino acid PET imaging: does it work for 11C-methionine?

Authors:  Gérard Moulin-Romsée; Eduard D'Hondt; Tjibbe de Groot; Jan Goffin; Raf Sciot; Luc Mortelmans; Johan Menten; Guy Bormans; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-01       Impact factor: 9.236

6.  Intra-individual comparison of ¹⁸F-FET and ¹⁸F-DOPA in PET imaging of recurrent brain tumors.

Authors:  Clemens Kratochwil; Stephanie E Combs; Karin Leotta; Ali Afshar-Oromieh; Stefan Rieken; Jürgen Debus; Uwe Haberkorn; Frederik L Giesel
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300
  6 in total
  3 in total

1.  L-type amino acid transporter (LAT) 1 expression in 18F-FET-negative gliomas.

Authors:  Franziska J Vettermann; Caroline Diekmann; Lorraine Weidner; Marcus Unterrainer; Bogdana Suchorska; Viktoria Ruf; Mario Dorostkar; Vera Wenter; Jochen Herms; Jörg-Christian Tonn; Peter Bartenstein; Markus J Riemenschneider; Nathalie L Albert
Journal:  EJNMMI Res       Date:  2021-12-14       Impact factor: 3.138

2.  Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas.

Authors:  Gaia Ninatti; Martina Sollini; Beatrice Bono; Noemi Gozzi; Daniil Fedorov; Lidija Antunovic; Fabrizia Gelardi; Pierina Navarria; Letterio S Politi; Federico Pessina; Arturo Chiti
Journal:  Neuro Oncol       Date:  2022-09-01       Impact factor: 13.029

3.  The Relationship Between IDH1 Mutation Status and Metabolic Imaging in Nonenhancing Supratentorial Diffuse Gliomas: A 11C-MET PET Study.

Authors:  Nijiati Kudulaiti; Huiwei Zhang; Tianming Qiu; Junfeng Lu; Abudumijiti Aibaidula; Zhengwei Zhang; Yihui Guan; Dongxiao Zhuang
Journal:  Mol Imaging       Date:  2019 Jan-Dec       Impact factor: 4.488
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.